News
PBH
66.79
-0.25%
-0.17
Top Prestige Executive Makes Notable Move With Company Stock
TipRanks · 16h ago
Heartland Opportunistic Value Equity Strategy Q4 2025 Portfolio Activity
Seeking Alpha · 1d ago
Oppenheimer Remains a Buy on Prestige Consumer Healthcare (PBH)
TipRanks · 3d ago
Weekly Report: what happened at PBH last week (0202-0206)?
Weekly Report · 5d ago
How Mixed Q3 Results, Buybacks and Pillar5 Deal At Prestige (PBH) Have Changed Its Investment Story
Simply Wall St · 5d ago
Prestige Consumer Healthcare (PBH) Margin Compression Reinforces Cautious Earnings Narratives
Simply Wall St · 6d ago
Prestige Consumer Healthcare Earnings Call Highlights Cash Strength
TipRanks · 02/07 00:18
Prestige Deal For Stampede Culinary Partners Reshapes Earnings And Valuation Potential
Simply Wall St · 02/06 17:11
Prestige Consumer price target lowered to $86 from $88 at Canaccord
TipRanks · 02/06 11:40
Prestige Consumer Healthcare narrows fiscal 2026 revenue outlook to $1.1B while advancing Clear Eyes supply recovery
Seeking Alpha · 02/05 22:25
Prestige (PBH) Q3 2026 Earnings Call Transcript
The Motley Fool · 02/05 14:52
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Prestige Consumer Healthcare (PBH), McKesson (MCK) and Bristol-Myers Squibb (BMY)
TipRanks · 02/05 14:20
Prestige Consumer Healthcare Reports Q3 Results, Narrows Outlook
TipRanks · 02/05 11:34
Prestige Consumer narrows FY26 adj EPS view to $4.54 from $4.54-$4.58
TipRanks · 02/05 11:21
Prestige Consumer reports Q3 adjusted EPS $1.14, consensus $1.16
TipRanks · 02/05 11:15
Earnings Scheduled For February 5, 2026
Benzinga · 02/05 11:11
Prestige Consumer Healthcare Non-GAAP EPS of $1.14 misses by $0.02, revenue of $283.4M misses by $3.12M
Seeking Alpha · 02/05 11:11
Prestige Consumer Narrows FY2026 Adj EPS Guidance from $4.54-$4.58 to $4.54 vs $4.55 Est; Narrows FY2026 Sales Guidance from $1.100B-$1.115B to $1.100B vs $1.107B Est
Benzinga · 02/05 11:05
Insights into Prestige Consumer Q3 Earnings
Benzinga · 02/05 11:04
*Prestige Consumer Hlthcr: Narrows Outlook Range of FY26 Revenue, Adj Diluted EPS >PBH
Dow Jones · 02/05 11:03
More
Webull provides a variety of real-time PBH stock news. You can receive the latest news about Prestige Consmr Healthcare Inc through multiple platforms. This information may help you make smarter investment decisions.
About PBH
Prestige Consumer Healthcare Inc. is a consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.